The Brazilian Nonproprietary Name or DCB, from the Portuguese Denominação Comum Brasileira is the official Portuguese nomenclature for
drugs
A drug is any chemical substance other than a nutrient or an essential dietary ingredient, which, when administered to a living organism, produces a biological effect. Consumption of drugs can be via inhalation, injection, smoking, ingestio ...
or
active ingredient
An active ingredient is any ingredient that provides biologically active or other direct effect in the diagnosis, cure, mitigation, treatment, or prevention of disease or to affect the structure or any function of the body of humans or animals.
...
s that have been approved by the
Brazilian Health Regulatory Agency (ANVISA) for use in
Brazil
Brazil, officially the Federative Republic of Brazil, is the largest country in South America. It is the world's List of countries and dependencies by area, fifth-largest country by area and the List of countries and dependencies by population ...
.
The consolidated list from October 2021 contains just over 12,300 items.
Every record has a numerical
identifier
An identifier is a name that identifies (that is, labels the identity of) either a unique object or a unique ''class'' of objects, where the "object" or class may be an idea, person, physical countable object (or class thereof), or physical mass ...
known as the DCB Number, used in contexts such as registrations, tenders and official documentation.
History
In 1970 Andrejus Korolkovas, from the Faculty of Pharmaceutical Sciences,
University of São Paulo
The Universidade de São Paulo (, USP) is a public research university in the Brazilian state of São Paulo, and the largest public university in Brazil.
The university was founded on 25 January 1934, regrouping already existing schools in ...
, was already publishing about the importance of a nomenclature to harmonize the names of drugs.
In the year 1981, a list of generic names that would be mandatory for a new registration of a medicine was published in the Official Gazette of the Union, by the Ministry of Health. A standardization of nomenclature was carried out, and the introduction of numerical codes that would allow the identification of the substances. In 1983 the use of the standard nomenclature in official documents was made mandatory.
See also
*
International Nonproprietary Name
*
British Approved Name
A British Approved Name (BAN) is the official, non-proprietary, or generic name given to a pharmaceutical substance, as defined in the British Pharmacopoeia (BP). The BAN is also the official name used in some countries around the world, because ...
*
United States Adopted Name
A United States Adopted Name (USAN) is a unique nonproprietary name assigned to a medication marketed in the United States. Each name is assigned by the USAN Council, which is co-sponsored by the American Medical Association (AMA), the United St ...
*
Interactive Terminology for Europe
Interactive Terminology for Europe (IATE) is the interinstitutional terminology database of the European Union. The project was launched in 1999 with the objective of creating a web-based interface for all EU terminology resources so as to make th ...
*
IUPAC nomenclature
IUPAC nomenclature is a set of recommendations for naming chemical compounds and for describing chemistry and biochemistry in general. The International Union of Pure and Applied Chemistry (IUPAC) is the international authority on chemical nomenc ...
References
{{Reflist
Pharmacological classification systems